Cost-effectiveness and budget impact of the community-based management of hypertension in Nepal study (COBIN): A retrospective analysis
The Lancet Global Health Sep 24, 2019
Krishnan A, et al. - The researchers performed a retrospective analysis of the community-based management of hypertension in Nepal (COBIN) study, a 12-month community-based hypertension management program of blood pressure monitoring and lifestyle counseling intervention, which showed success in reducing blood pressure, in order to quantify its budget impact and cost-effectiveness of its scale-up. They focused on two scenarios while estimating costs per participant and total costs of a national scale-up of the COBIN program: scenario A, delivery of the intervention to only people aged 25–65 years with hypertension; and scenario B, delivery of the intervention to all adults aged 25–65 years regardless of hypertension status. The first-year budget impact of US$7·1 million in scenario A and $10·8 million in scenario B was estimated from a health system perspective. With each subsequent year, a decrease in the costs by nearly 50% occurred. In both scenarios, the program is predicted to be remarkably cost-effective when compared with the WHO thresholds for cost-effectiveness for Nepal. Policymakers could consider this intervention in order to meet the UN Sustainable Development Goal of reducing premature mortality from non-communicable diseases.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries